| Literature DB >> 27375562 |
Xiaojuan Yang1, Jumei Zhang1, Shubo Yu1, Qingping Wu1, Weipeng Guo1, Jiahui Huang1, Shuzhen Cai1.
Abstract
Staphylococcus aureus, particularly methicillin-resistant S.aureus (MRSA), is a life-threatening pathogen in humans, and its presence in food is a public health concern. MRSA has been identified in foods in China, but little information is available regarding MRSA in ready-to-eat (RTE) foods. We aimed to investigate the prevalence of S. aureus and MRSA in Chinese retail RTE foods. All isolated S. aureus were tested for antimicrobial susceptibility, and MRSA isolates were further characterized by multilocus sequence typing (MLST) and staphylococcal cassette chromosome mec (SCCmec) typing. Of the 550 RTE foods collected from 2011 to 2014, 69 (12.5%) were positive for S. aureus. Contamination levels were mostly in the range of 0.3-10 most probable number (MPN)/g, with five samples exceeding 10 MPN/g. Of the 69 S. aureus isolates, seven were identified as MRSA by cefoxitin disc diffusion test. Six isolates were mecA-positive, while no mecC-positive isolates were identified. In total, 75.8% (47/62) of the methicillin-susceptible S. aureus isolates and all of the MRSA isolates were resistant to three or more antibiotics. Amongst the MRSA isolates, four were identified as community-acquired strains (ST59-MRSA-IVa (n = 2), ST338-MRSA-V, ST1-MRSA-V), while one was a livestock-associated strain (ST9, harboring an unreported SCCmec type 2C2). One novel sequence type was identified (ST3239), the SCCmec gene of which could not be typed. Overall, our findings showed that Chinese retail RTE foods are likely vehicles for transmission of multidrug-resistant S. aureus and MRSA lineages. This is a serious public health risk and highlights the need to implement good hygiene practices.Entities:
Keywords: Staphylococcus aureus; antibiotic resistance; methicillin-resistant; prevalence; ready-to-eat foods
Year: 2016 PMID: 27375562 PMCID: PMC4895929 DOI: 10.3389/fmicb.2016.00816
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 1Map of China showing the locations of the 24 cities where RTE samples were collected.
Prevalence and load of .
| Cooked pork | 119 | 15 (12.6) | 10 | 5 | ||
| Cooked chicken | 153 | 15 (9.8) | 6 | 8 | 1 | |
| Cooked duck | 127 | 17 (13.4) | 7 | 7 | 3 | |
| Cold vegetable dishes in sauce | 53 | 6 (11.3) | 4 | 2 | ||
| Cold noodles | 52 | 10 (19.2) | 5 | 4 | 1 | |
| Fired rice/sushi | 46 | 6 (13.0) | 3 | 3 | ||
| Total | 550 | 69 (12.5) | 35 | 29 | 5 | |
Prevalence and characteristics of methicillin-resistant .
| Guagnzhou | Cold noodles | 112 | S8 | + | + | ST338 | V (5C2) | AMP-FOX-P-C-TE-K-E-DA |
| Sanya | Cold noodles | 560 | S27 | + | + | ST3239 | NT (2/) | AMP-FOX-P-CN-K-SXT-E-DA-RD |
| Nanning | Cooked duck | 678 | S33 | + | + | ST59 | IVa (2B) | AMP-FOX-P-TE-K-E-DA |
| Fuzhou | Cooked chicken | 2236 | S51 | + | + | ST9 | AMP-FOX-P-C-TE-CIP-CN-K-SXT-E-DA | |
| Nanning | Cooked duck | 2284 | S53 | + | + | ST59 | IVa (2B) | AMP-FOX-P-TE |
| Nanchang | Fired rice/sushi | 2512 | S66 | + | + | ST1 | V (5C2) | AMP-FOX-P |
| Haikou | Cold vegetables dishes in sauce | 509 | S23 | + | − | AMP-FOX-P-E |
Novel sequence type. NT, not typeable. /, no amplification product. .
AMP, ampicillin; E, erythromycin; DA, clindamycin; FOX, cefoxitin; RD, rifampicin; P, penicillin G; C, chloramphenicol; TE, tetracycline; CIP, ciprofloxacin; CN, gentamicin; K, kanamycin; SXT, trimethoprim-sulfamethoxazole.
Antimicrobial resistance susceptibility profiles of methicillin-susceptible .
| Ampicillin (AMP, 10 μg) | 61 (98.4) | 0 (0.0) | 1 (1.6) |
| Cephalothin (KF, 30 μg) | 0 (0.0) | 0 (0.0) | 62 (100) |
| Cefoxitin (FOX, 30 μg) | 0 (0.0) | 0 (0.0) | 62 (100) |
| Penicillin G (P, 10 μg) | 61 (98.4) | 0 (0.0) | 1 (1.6) |
| Choramphenicol (C, 30 μg) | 4 (6.5) | 1 (1.6) | 57 (91.9) |
| Tetracycline (TE, 30 μg) | 27 (43.5) | 0 (0.0) | 38 (56.5) |
| Ciprofloxacin (CIP, 5 μg) | 1 (1.6) | 1 (1.6) | 60 (96.8) |
| Amikacin (AK, 30 μg) | 1 (1.6) | 0 (0.0) | 61 (98.4) |
| Gentamicin (CN, 10 μg) | 6 (9.7) | 0 (0.0) | 56 (90.3) |
| Kanamycin (K, 30 μg) | 10 (16.1) | 8 (12.9) | 44 (71.0) |
| Trimethoprim-Sulfamethoxazole (SXT, 25 μg) | 11 (17.8) | 2 (3.2) | 49 (79.0) |
| Erythromycin (E, 15 μg) | 17 (27.4) | 5 (8.1) | 40 (64.5) |
| Clindamycin (DA, 2 μg) | 7 (11.3) | 2 (3.2) | 53 (85.5) |
| Rifampicin (RD, 5 μg) | 4 (6.5) | 0 (0.0) | 58 (93.5) |
| Linezolid (LZD, 30 μg) | 1 (1.6) | 0 (0.0) | 61 (98.4) |
| Quinupristin/dalfopristin (QD, 15 μg) | 0 (0.0) | 0 (0.0) | 62 (100) |
| Vancomycin (VA, MIC) | 0 (0.0) | 0 (0.0) | 62 (100) |
| Pansusceptible | 0 (0.0) | ||
| ≥1 Antimicrobial | 62 (100) | ||
| ≥3 Antimicrobial | 47 (75.8) | ||
| ≥6 Antimicrobial | 9 (12.9) | ||